Article
Small nucleolar RNAs in plasma and their discriminatory power as diagnostic biomarkers of Alzheimer’s disease
2021-05-07
Abstract excerpt
<h4>A bstract </h4> The clinical diagnosis of Alzheimer’s disease, at its early stage, remains a difficult task. Advanced imaging technologies and laboratory assays to detect Aβ peptides Aβ42 and Aβ40, total and phosphorylated tau in CSF provide a set of biomarkers of developing AD brain pathology and facilitate the diagnostic process. The search for biofluid biomarkers, other than in CSF, and the development of b...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Amyotrophic Lateral Sclerosis Research
- Cancer-related molecular mechanisms research
- Extracellular vesicles in disease
- Long-Term Effects of COVID-19
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Single-cell and spatial transcriptomics
Identifiers and source
- Literature Corpus work
- 60bc2bc4-a2fd-5c5d-a25a-474afd9f44a2
- DOI
- 10.1101/2021.05.04.21256076
